Clarivate forecasts 2026 adjusted EBITDA of $865 million to $885 million
Clarivate forecasts adjusted EBITDA of $865 million to $885 million for 2026 following the Life Sciences sale.
Related stories
Adeia shares fall 15.1% after company cuts FY profit forecast
Adeia shares hit a more than 10-month low and were last down 15.1% after the company cut its full-year profit forecast.
M impact | EARNINGS | Nov 03, 2026, 02:34 PM UTC
Zebra Raises 2026 Sales Growth Outlook to About 17%
Zebra Technologies raised its full-year 2026 sales growth outlook to about 17%.
M impact | EARNINGS | Nov 03, 2026, 02:33 PM UTC
Upstart Reports Results for Quarter Ended September 30
L impact | EARNINGS | Nov 03, 2026, 02:32 PM UTC
Gartner Reports Results for Quarter Ended September 30
L impact | EARNINGS | Nov 03, 2026, 02:32 PM UTC
Kolte-Patil Developers Reports September-Quarter Revenue of 3.34 Billion Rupees
M impact | EARNINGS | Nov 03, 2026, 02:31 PM UTC
Vijaya Diagnostic Centre Reports Sept-Quarter Consolidated Profit of 594.7 Million Rupees
M impact | EARNINGS | Nov 03, 2026, 02:29 PM UTC